Ophthalmology Product Articles & Analysis

2 news found

BRIM Biotechnology, Inc. and Ora, Inc. announce new partnership to accelerate the development of regenerative peptide therapy, BRM421 for Dry Eye Syndrome

(“BRIM”) a clinical-stage company developing novel regenerative therapies in ophthalmology, today announces it has entered into a new strategic partnership with Ora®, Inc. ...

May 17, 2022

ByBRIM Biotechnology, Inc.

PolyActiva appoints Tracy Valorie, ophthalmic industry expert and former Bausch + Lomb executive, to its Board of Directors

Melbourne, Australia - 30 October 2020: PolyActiva Pty Ltd, a clinical-stage ophthalmology biopharmaceutical company, today announced the appointment of highly experienced ophthalmic industry expert, Tracy Valorie, as a new member to the company's Board of Directors. Ms Valorie is recognized in the industry for her success in building and leading high performing teams and for ...

Oct. 30, 2020

ByPolyActiva Pty Ltd.

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you